NEW YORK (Reuters Health) – Children with severe combined immunodeficiency (SCID) do better when they receive stem cell transplantation during infancy, according to a systematic review published online…
NEW YORK (Reuters Health) – The nonselective beta-blocker carvedilol and the beta-1-selective beta-blockers metoprolol succinate and bisoprolol have significantly different treatment effects in patients with chronic heart failure…
NEW YORK (Reuters Health) – The “dramatic benefits” of probiotic supplements for reducing death and necrotizing enterocolitis (NEC) in very low birth weight (VLBW) preterm neonates have been…
NEW YORK (Reuters Health) – Clopidogrel reloading does not benefit patients undergoing percutaneous coronary intervention (PCI) who are already on chronic clopidogrel therapy, Italian researchers reported online April…
NEW YORK (Reuters Health) – In older patients with normal lipids but high C-reactive protein, primary prevention therapy with rosuvastatin (Crestor) does not lower mortality, but it does…
NEW YORK (Reuters Health) – Anemia increases the risk of bleeding and death after percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), a new study shows.…
NEW YORK (Reuters Health) – Intra-arterial fibrinolysis improves outcomes after acute ischemic stroke, a meta-analysis confirms — and although the treatment increases the risk of hemorrhage, that doesn’t…
NEW YORK (Reuters) – In older patients on warfarin therapy, treatment with cotrimoxazole significantly raises the risk of upper gastrointestinal tract hemorrhage, new research shows. The increased hemorrhage…
NEW YORK (Reuters Health) – Octogenarians with heart failure have a higher risk of in-hospital death after defibrillator or pacemaker placement, compared to younger patients, new research shows.…
NEW YORK (Reuters Health) – Compared with open repair of abdominal aortic aneurysm (AAA), endovascular repair has some early benefits — but overall mortality rates converge within a…